Literature DB >> 10339488

Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1.

D Mechtcheriakova1, A Wlachos, H Holzmüller, B R Binder, E Hofer.   

Abstract

Vascular endothelial cell growth factor (VEGF) is a major regulator of angiogenesis. We report here that treatment of endothelial cells with VEGF leads to upregulation of tissue factor mRNA and protein expression on the cell surface. Reporter gene studies show that transcriptional activation of the tissue factor gene by VEGF is mediated by a GC-rich promoter element containing overlapping binding sites for Sp1 and EGR-1. As shown by immunofluorescence and electrophoretic mobility shift assays, upon VEGF treatment EGR-1 rapidly accumulates in the nucleus and binds to its respective recognition site in the tissue factor promoter. Sp1 occupies this element in unstimulated cells and seems to be partially displaced by increasing amounts of EGR-1. Transfection of endothelial cells with an EGR-1 expression plasmid mimics the upregulation of tissue factor transcription observed after VEGF treatment. In contrast, NFkappaB, the major transcription factor involved in tissue factor upregulation by inflammatory stimuli, is not activated by VEGF. These data show that VEGF induces a response in endothelial cells largely distinct from inflammatory stimuli, and suggest that EGR-1 is a major mediator of the activation of the tissue factor and possibly other VEGF-responsive genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339488

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  HIF1-alpha Regulates Acinar Cell Function and Response to Injury in Mouse Pancreas.

Authors:  Min-Jung Park; Sapna Iyer; Xiang Xue; Juliana Bragazzi Cunha; Shufang Gu; David Moons; Steven W Pipe; John A Williams; Diane M Simeone; Yatrik M Shah; M Bishr Omary
Journal:  Gastroenterology       Date:  2018-02-01       Impact factor: 22.682

Review 3.  Signal transduction in vasculogenesis and developmental angiogenesis.

Authors:  Sunita Patel-Hett; Patricia A D'Amore
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

4.  Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney.

Authors:  Danita Eatman; Mohammed F Layas; Mohamed A Bayorh
Journal:  Kidney Blood Press Res       Date:  2010-06-23       Impact factor: 2.687

Review 5.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

6.  Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.

Authors:  Debasish Maiti; Zhenhua Xu; Elia J Duh
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

7.  Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro.

Authors:  Zhengyu Pang; Laura E Niklason; George A Truskey
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

8.  Phorbol 12-myristate 13-acetate (PMA) responsive sequence in Galphaq promoter during megakaryocytic differentiation. Regulation by EGR-1 and MAP kinase pathway.

Authors:  Gauthami Jalagadugula; Danny N Dhanasekaran; A Koneti Rao
Journal:  Thromb Haemost       Date:  2008-11       Impact factor: 5.249

9.  Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells.

Authors:  Md Ruhul Abid; Robert J Nadeau; Katherine C Spokes; Takashi Minami; Dan Li; Shou-Ching Shih; William C Aird
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-11       Impact factor: 8.311

10.  Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.

Authors:  J E Bluff; S R Menakuru; S S Cross; S E Higham; S P Balasubramanian; N J Brown; M W Reed; C A Staton
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.